Skip to main content
. Author manuscript; available in PMC: 2017 Nov 10.
Published in final edited form as: Mayo Clin Proc. 2016 May 10:S0025-6196(16)00125-7. doi: 10.1016/j.mayocp.2016.02.012

TABLE 3.

Surrogate-Based Approvals for Which Subsequent Trials Report an OS Benefit or a Lack of Survival Benefit or for Which No Trials Exist Showing or Refuting a Survival Benefit

Indication Approvals (No. [%])
Proven OS benefit No OS benefit OS benefit unknown
Total (n=55) 10 (18.2) 15 (27.3) 30 (54.5)
Accelerated approval (n=25) 6 (24.0) 3 (12.0) 16 (64.0)
Traditional approval (n=30) 4 (13.3) 12 (40.0) 14 (46.7)

OS =overall survival.